Stay current with the latest NMPA regulatory updates affecting health supplements in China. ACC Biotech provides expert guidance for OEM brands navigating these changes.
China continues to strengthen its health supplement regulatory framework in 2026, with NMPA introducing several important updates that affect OEM manufacturers and brand owners. Understanding these changes is essential for any company selling supplements in mainland China.
NMPA has expanded the list of ingredients eligible for the simpler filing pathway, including additional vitamins, minerals, and botanical extracts. This reduces market entry time for many supplement categories from years to months.
New permissible health functions have been added to the Blue Hat system, including immune support sub-categories, gut health functions, and cognitive support claims. OEM brands can now access more diverse marketing positions.
New advertising regulations limit health claims and require pre-approval for certain types of marketing content. Penalties for non-compliant advertising have increased significantly.
NMPA has updated GMP requirements to align more closely with international standards, including enhanced traceability, electronic batch records, and stricter contaminant testing.
Cross-border e-commerce policies continue evolving in 2026, with adjustments to the personal use allowance, expanded list of CBEC-eligible products, and new requirements for Chinese-language customer service. These changes create new opportunities while raising compliance expectations.
ACC Biotech (www.accbiotech.com) maintains active monitoring of Chinese regulatory developments. Our regulatory team provides timely updates, compliance assessments, and strategic recommendations for OEM clients. As a Hong Kong-based one-stop supplement OEM, we combine manufacturing capabilities with deep China regulatory expertise.
Don't let regulatory complexity slow your China expansion. ACC Biotech (www.accbiotech.com) offers complete OEM services from our Hong Kong base, with regulatory expertise covering NMPA, cross-border e-commerce, and Hainan Free Trade Port pathways. Contact us to discuss how the 2026 updates create opportunities for your supplement brand.
More from ACC Biotech: visit our international certifications, production equipment page, or contact us to discuss your project.
